Avadel Pharmaceuticals plc (AVDL) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 77.47M | 68.13M | 52.51M | 50.41M | 50.02M | 41.5M | 27.18M | 19.45M | 7.01M | 1.5M | 0 | 0 |
| Revenue Growth % | 54.86% | 64.15% | 93.21% | 159.14% | 613.22% | 2674.33% | - | - | - | - | - | - |
| Cost of Goods Sold | -3M | 6.37M | 5.58M | 4.81M | 6.16M | 2.79M | 1.52M | 693K | 117K | 36K | 0 | 586K |
| COGS % of Revenue | -3.87% | 9.34% | 10.62% | 9.55% | 12.3% | 6.72% | 5.6% | 3.56% | 1.67% | 2.41% | - | - |
| Gross Profit | 80.47M | 61.76M | 46.93M | 45.6M | 43.87M | 38.72M | 25.66M | 18.76M | 6.9M | 1.46M | 0 | -586K |
| Gross Margin % | 103.87% | 90.66% | 89.38% | 90.45% | 87.7% | 93.28% | 94.4% | 96.44% | 98.33% | 97.59% | - | - |
| Gross Profit Growth % | 83.42% | 59.53% | 82.94% | 143.06% | 536.07% | 2551.78% | - | 3301.37% | 1819.95% | 691.09% | - | - |
| Operating Expenses | 78.53M | 52.88M | 49.94M | 48.9M | 44.2M | 51.46M | 51.69M | 43.66M | 42.01M | 51M | 28.3M | 22.63M |
| OpEx % of Revenue | 101.37% | 77.62% | 95.09% | 96.99% | 88.35% | 123.98% | 190.19% | 224.44% | 598.9% | 3409.16% | - | - |
| Selling, General & Admin | 51.52M | 48.62M | 45.58M | 44.62M | 40.39M | 47.41M | 48.62M | 41.3M | 39.16M | 46.78M | 24.47M | 16.39M |
| SG&A % of Revenue | 66.51% | 71.37% | 86.8% | 88.52% | 80.75% | 114.22% | 178.91% | 212.31% | 558.28% | 3126.87% | - | - |
| Research & Development | 27.01M | 4.25M | 4.35M | 4.27M | 3.8M | 4.05M | 3.07M | 2.36M | 2.85M | 4.22M | 3.83M | 6.24M |
| R&D % of Revenue | 34.87% | 6.25% | 8.29% | 8.48% | 7.6% | 9.76% | 11.29% | 12.13% | 40.62% | 282.29% | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 1.94M | 8.88M | -3M | -3.3M | -327K | -12.74M | -26.04M | -24.9M | -35.11M | -49.54M | -28.3M | -23.22M |
| Operating Margin % | 2.5% | 13.04% | -5.71% | -6.54% | -0.65% | -30.7% | -95.79% | -128% | -500.57% | -3311.56% | - | - |
| Operating Income Growth % | 692.35% | 169.73% | 88.47% | 86.76% | 99.07% | 74.28% | 8% | -7.25% | -106.18% | -88.05% | 1.15% | -0.35% |
| EBITDA | 3.05M | 9.95M | -2.18M | -2.63M | 708K | -12.3M | -25.49M | -24.92M | -34.52M | -48.94M | -27.71M | -22.63M |
| EBITDA Margin % | 3.94% | 14.61% | -4.14% | -5.22% | 1.42% | -29.65% | -93.8% | -128.09% | -492.09% | -3271.39% | - | - |
| EBITDA Growth % | 331.07% | 180.88% | 91.46% | 89.45% | 102.05% | 74.86% | 8% | -10.11% | -107.57% | -87.52% | 2.32% | 1.33% |
| D&A (Non-Cash Add-back) | 1.11M | 1.07M | 825K | 668K | 1.03M | 437K | 541K | -18K | 595K | 601K | 588K | 586K |
| EBIT | 2.47M | 8.85M | -2.6M | -2.26M | 283K | -11.62M | -24.66M | -26.53M | -34.21M | -62.05M | -28.11M | -24.11M |
| Net Interest Income | -2.42M | -2.35M | -2.24M | -2.7M | -2.82M | -2.72M | -2.59M | -2.35M | -1.98M | -2.29M | -3.26M | -3.25M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.42M | 2.35M | 2.24M | 2.7M | 2.82M | 2.72M | 2.59M | 2.35M | 1.98M | 2.29M | 3.26M | 3.25M |
| Other Income/Expense | -1.88M | -2.39M | -1.84M | -1.67M | -2.21M | -1.59M | -1.21M | -3.99M | -1.07M | -14.8M | -3.07M | -4.15M |
| Pretax Income | 54K | 6.5M | -4.84M | -4.96M | -2.54M | -14.33M | -27.25M | -28.89M | -36.19M | -64.34M | -31.36M | -27.36M |
| Pretax Margin % | 0.07% | 9.53% | -9.22% | -9.85% | -5.07% | -34.53% | -100.26% | -148.49% | -515.9% | -4300.94% | - | - |
| Income Tax | 34K | -3.17M | 78K | 80K | 88K | -509K | 93K | -100K | 89K | 90K | -580K | 85K |
| Effective Tax Rate % | 62.96% | -48.81% | -1.61% | -1.61% | -3.47% | 3.55% | -0.34% | 0.35% | -0.25% | -0.14% | 1.85% | -0.31% |
| Net Income | 20K | 9.66M | -4.92M | -5.04M | -2.63M | -13.82M | -27.34M | -28.79M | -36.27M | -64.43M | -30.78M | -27.45M |
| Net Margin % | 0.03% | 14.19% | -9.37% | -10% | -5.25% | -33.3% | -100.6% | -147.98% | -517.17% | -4306.95% | - | - |
| Net Income Growth % | 100.76% | 169.92% | 82.01% | 82.48% | 92.76% | 78.55% | 11.18% | -4.87% | -80.06% | -1.56% | -16.5% | -23.09% |
| Net Income (Continuing) | 20K | 9.66M | -4.92M | -5.04M | -2.63M | -13.82M | -27.34M | -28.79M | -36.27M | -64.43M | -30.78M | -27.45M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00 | 0.10 | -0.05 | -0.05 | -0.03 | -0.14 | -0.30 | -0.33 | -0.41 | -0.83 | -0.48 | -0.43 |
| EPS Growth % | 100.67% | 171.43% | 83.33% | 84.85% | 92.68% | 83.13% | 37.5% | 23.26% | -24.24% | 22.43% | -6.67% | -13.16% |
| EPS (Basic) | 0.00 | 0.10 | -0.05 | -0.05 | -0.03 | -0.14 | -0.30 | -0.33 | -0.41 | -0.83 | -0.48 | -0.43 |
| Diluted Shares Outstanding | 101.28M | 99.09M | 96.6M | 96.39M | 96.3M | 96.15M | 91.69M | 85.93M | 89.38M | 77.25M | 63.89M | 63.23M |
| Basic Shares Outstanding | 97.1M | 96.73M | 96.6M | 96.39M | 96.3M | 96.15M | 91.69M | 85.93M | 89.38M | 77.25M | 63.89M | 63.23M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |